FT DIGITAL DIALOGUES | Building resilience in pharma R&D by decentralising and digitising
Wednesday 3 February 4:00pm GMT, 11am EST
IN PARTNERSHIP WITH
This FT Digital Dialogue on Innovative Clinical Research Strategies, organised in partnership with ICON plc, will discuss how to design and run more resilient trials in an uncertain world, where the need to decentralise is driving investment in new technology solutions and changing the pharma R&D landscape.
US Pharma and Biotech Correspondent
Executive Vice-President, Research & Development, Oncology
Chief Development Officer
Executive Vice President Chief Medical Officer
President Clinical Research Services
KEY TALKING POINTS
How is trial design evolving in terms of data collection, safety reporting, tracking and other processes?
What are some of the challenges around moving to remote study management and off-site monitoring?
What can be done to manage the risks and consequences of trials being suspended and re-started?
How could new approaches to clinical trial management affect access to patient populations and how can direct patient support services be improved?
How can relationships with regulators, patients and other stakeholders evolve to accommodate new processes and solutions?
REGISTER FOR YOUR COMPLIMENTARY PASS
FT Live events keep you connected and informed in an uncertain and constantly changing world. All access, digital passes include access to all the live sessions PLUS all sessions on demand for 30 days. Join the conversation.